Skip to content
Fischer Medical Ventures logo

Fischer Medical Ventures

FISCHER NSE
₹26.13 down 0.53 (1.99%)
Market Cap
₹1,710 Cr
P/E
68.76

Fischer Medical Ventures (FISCHER) share price was ₹26.66 at the 28 Oct 2026 close; market capitalisation ₹1,745 Cr; P/E (TTM) 70.16; sector Chemicals. The share price fell 75.6% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 249.5% year on year to ₹81.92 Cr and net profit fell 22.0% year on year to ₹3.79 Cr (compared with Jun 2025). Promoters held 63.08% of Fischer Medical Ventures in Sep 2026, up 0.93 percentage points from Jun 2026. Its Tapetide Score is 44/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹26.66 −88.69 −76.89% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals
Market Cap
₹1,710 Cr
P/E (TTM)
68.76
EBITDA
₹55.40 Cr
Return on Equity
8.11%
Debt to Equity
0.28
Book Value
₹6.99
EPS (TTM)
₹0.38
52W High
₹121.34
52W Low
₹21.78

Price-based figures as of 29 Oct 2026, 10:44 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Chemicals › Commodity Chemicals › Medical Equipment & Supplies

₹1,463.9047.0914,838 Cr4.780.24%10.18%13.33%2,115 Cr313 Cr
₹26.1368.761,710 Cr3.740.20%8.11%12.69%373 Cr24 Cr
₹308.20147.461,640 Cr2.580.66%2.26%4.82%468 Cr11 Cr
₹550.0026.071,283 Cr2.630.00%22.63%26.37%201 Cr34 Cr
₹178.0131.73980 Cr4.030.00%10.83%11.51%289 Cr31 Cr
——832 Cr5.310.00%13.22%19.52%——
Median 6 companies₹308.2047.091,461 Cr3.890.10%10.51%13.01%373 Cr31 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

44 Weak
Overall score

Data confidence 98/100

Category scores

Quality Poor 31
Returns, margins, earnings quality 22% weight
Valuation Poor 33
Cheap vs sector & own history 24% weight
Growth Strong 99
Sales & profit trajectory 9% weight
Financial Health Average 48
Solvency, leverage, coverage 9% weight
Momentum Poor 15
Trend strength, vol-adjusted 12% weight
Ownership Strong 66
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is expected to give good quarter
  • Promoter holding has increased by 0.94% over last quarter.

Weaknesses

3
  • Stock is trading at 5.51 times its book value
  • Company has a low return on equity of 5.74% over last 3 years.
  • Company has high debtors of 342 days.

Technical Indicators

Oscillators

Bearish

Bearish
3
Neutral
5
Bullish
1

Overall

Bearish

Bearish
13
Neutral
5
Bullish
1

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
186%

change over 1 year

Net Income Growth
—

Cash Flow Change
-17.41%

change over 1 year

EBITDA Margin Change
300%

change over 1 year Operating margin 13.73% · Jun 2026

Quarterly Results

Particulars Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
20.79
10.12
39.66
11.75
49.17
23.44
86.31
101
97.54
81.92
Expenses
0
18.28
10.33
39.16
11.38
46.66
19.45
70.09
79.53
101
70.67
Operating Profit
0
2.51
-0.21
0.5
0.37
2.51
3.99
16.22
21.57
-3.77
11.25
OPM %
—
12.07%
-2.08%
1.26%
3.15%
5.1%
17.02%
18.79%
21.34%
-3.87%
13.73%
Other Income
0
0.47
0.69
0.05
0.38
0.15
7.47
2.48
1.09
0.77
1.48
Interest
0
0.05
0.13
0.05
0.07
0.23
0.66
0.92
0.64
3.66
3.54
Depreciation
0
0.18
0.28
0.29
0.56
0.51
0.77
0.51
0.77
0.93
1.36
PBT
0
2.75
0.07
0.21
0.12
1.92
10.03
17.27
21.25
-7.59
7.83
Tax %
—
6.18%
271.43%
-38.1%
350%
26.04%
51.55%
19.46%
9.18%
64.03%
51.6%
Net Profit
0
2.59
-0.12
0.29
-0.29
1.31
4.86
13.9
19.23
-12.44
3.79
EPS (₹)
0
0.05
0
0.01
-0.01
0.02
0.07
0.21
0.3
-0.19
0.06
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
21
111
308
367
Expenses
0
19
107
265
322
Operating Profit
0
2
3
43
45
OPM %
11%
9%
3%
14%
12%
Other Income
0
0
1
12
6
Interest
0
0
0
6
9
Depreciation
0
0
2
3
4
PBT
0
2
3
47
39
Tax %
—
13%
37%
33%
—
Net Profit
0
2
1
31
24
EPS (₹)
-0.24
0.03
0.02
0.49
0.38
Div. Payout %
0%
0%
22%
1%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.17
54
64
65
Reserves
0
28
274
320
Borrowings
1
2
85
107
Other Liabilities
0
4
34
179
Total Liabilities
0
86
457
671
Fixed Assets
0
15
24
32
CWIP
0
0
1
3
Investments
0
1
7
118
Other Assets
0
70
425
519
Total Assets
0
86
457
671
Figures in ₹ Crores

Cash Flow

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
-7
-86
-101
Investing
—
-29
-125
-5
Financing
—
37
315
14
Net Cash Flow
—
1
103
-92
Free Cash Flow
—
-8
-91
6
CFO/OP
—
-392
-2,555
-194
Figures in ₹ Crores

Ratios

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
398
251
342
Inventory Days
—
99
36
58
Days Payable
—
48
82
466
Cash Conversion Cycle
—
449
205
-67
Working Capital Days
—
498
42
159
ROCE %
—
5%
1%
11%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Fischer Medical Ventures insights

61 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

DIIs1.26%Promot.63.08%Others6.12%FIIs6.71%Public22.82%As ofSep 2026
6.81% of promoter holding pledged as of Sep 2026

Documents

Frequently Asked Questions about Fischer Medical Ventures

What does Fischer Medical Ventures Ltd do?
Fischer Medical Ventures Ltd, earlier known as Fischer Chemic Ltd, leads a healthcare-technology group. It makes and services medical-imaging equipment and provides AI-based health screening and digital-health solutions. Its MRI manufacturing plant is located at Andhra Pradesh MedTech Zone (AMT...
Where is Fischer Medical Ventures Ltd (FISCHER) listed?
Fischer Medical Ventures Ltd trades as FISCHER on the NSE and under code 524743 on the BSE.
Which sector does Fischer Medical Ventures Ltd belong to?
Fischer Medical Ventures Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd has a market capitalisation of ₹1,710 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd trades at a PE ratio of 68.76 as of 29 Oct 2026, on earnings per share of ₹0.38, against a book value of ₹6.99 per share.
What is the 52-week high and low of Fischer Medical Ventures Ltd?
Over the last 52 weeks Fischer Medical Ventures Ltd has traded between ₹21.78 and ₹121.34 as of 29 Oct 2026.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd has a dividend yield of 0.19%.
What is the Return on Equity (ROE) of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd reported a return on equity of 8.11%. Its debt-to-equity ratio is 0.28.

Company Information

Fischer Medical Ventures Ltd, earlier known as Fischer Chemic Ltd, leads a healthcare-technology group. It makes and services medical-imaging equipment and provides AI-based health screening and digital-health solutions. Its MRI manufacturing plant is located at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam.[1]

CEO Mr. Ravindran Govindan LLB
Employees 40
Listed 2005-06-08
Face Value ₹ 1
Shares Outstanding 65,45,15,470

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FISCHER.md for Fischer Medical Ventures Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More